{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:57:32Z","timestamp":1793908652218,"version":"4.8.0"},"reference-count":27,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently the most prevalent cause of chronic hepatic disease worldwide. Recently, the association between MASLD and renal injury has emerged as an additional factor impacting the clinical course of MASLD.  Objective: The present study evaluated the clinical association in patients with obesity.  Methods: This study enrolled patients classified as having obesity class II and III (BMI &gt;35 kg\/m2) and MASLD from an obesity surgical treatment center. The diagnosis criteria for MASLD included the presence of hepatic steatosis as indicated by histology or imaging assessments. We use Fibrosis-4 (FIB-4) and NAFLD fibrosis score (NSF) to assess and determine the presence of liver fibrosis. The glomerular filtration rate (GRF) was determined using CKD-EPI (chronic kidney disease epidemiology collaboration) equation, with GFR levels \u226590 and &lt;120 mL\/min\/1,73 m2 considered within the normal range.  Results: The study comprised a total of 560 individuals with obesity grade II and III, 325 individuals with MASLD. Among these, 422 (75.4%) patients were female, and the mean age was 36\u00b110 years. Systemic arterial hypertension (SAH) was present in 162 (41.1%) patients, and 218 (42.8 %) were diagnosed with type 2 Diabetes Mellitus (T2DM). A total of 286 individuals (51.1%) had a GFR below 114 mL\/min, with 183 (64%) of them exhibiting a higher degree of liver fibrosis, as indicated by FIB-4 &gt;0.54.  Conclusion: In patients with obesity classified as grades II and III, age emerged as the primary determinant leading to decline in GFR. Furthermore, glomerular hyperfiltration could be an early sign of progression to chronic kidney disease. Nonetheless, the progression of hepatic fibrosis could also be a significant factor contributing to impaired renal function.<\/jats:p>","DOI":"10.1590\/s0004-2803.24612025-008","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:05:27Z","timestamp":1746183927000},"source":"Crossref","is-referenced-by-count":3,"title":["RENAL INJURY AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IN PATIENTS WITH OBESITY"],"prefix":"10.1590","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4728-4162","authenticated-orcid":false,"given":"Kellyane Dias","family":"CARVALHO","sequence":"first","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3833-9742","authenticated-orcid":false,"given":"Cl\u00e1udia","family":"DALTRO","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1115-688X","authenticated-orcid":false,"given":"Carla","family":"DALTRO","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7698-6919","authenticated-orcid":false,"given":"Helma Pinchemel","family":"COTRIM","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella ME","year":"2023","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi ZM","year":"2023","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne CD","year":"2020","journal-title":"J. Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: An updated meta-analysis","volume":"71","author":"Mantovani A","year":"2022","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhep.2020.03.003","article-title":"Incidence of chronic kidney disease in patients with non-alcoholic fatty liver disease","volume":"73","author":"Zou ZY","year":"2020","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s11695-007-9147-6","article-title":"Prevalence and severity of sleep apnea in a group of morbidly obese patients","volume":"17","author":"Daltro C","year":"2007","journal-title":"Obes Surg"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2009.215","article-title":"Does bariatric surgery reduce the severity of NAFLD?","author":"Cotrim HP","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1007\/s11695-010-0212-1","article-title":"Nonalcoholic Fatty Liver Disease Associated with Obstructive Sleep Apnea: Just a Coincidence?","volume":"20","author":"Daltro C","year":"2010","journal-title":"Obes Surg"},{"key":"ref9","series-title":"Defining Adult Overweight & Obesity Division of Nutrition, Physical Activity, and Obesity","year":"2022"},{"key":"ref10","article-title":"International Diabetes Federation re-defines metabolic syndrome","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1244405","DOI":"10.3389\/fendo.2023.1244405","article-title":"Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease","volume":"14","author":"Semmler G","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref12","first-page":"S20","article-title":"Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-American Diabetes Association","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling RK","year":"2006","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis","volume":"112","author":"McPherson S","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah AG","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo P","year":"2007","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3748\/wjg.v19.i8.1219","article-title":"NAFLD fibrosis score: A prognostic predictor for mortality and liver complications among NAFLD patients","volume":"19","author":"Treeprasertsuk S","year":"2013","journal-title":"World J Gastroenterol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/ckj\/sfaa123","article-title":"Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes consensus conference","volume":"13","author":"Levey AS","year":"2020","journal-title":"Clin Kidney J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey AS","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref20","article-title":"Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement - 2023","volume":"121","author":"Feitosa ADM","year":"2024","journal-title":"Arq Bras Cardiol"},{"key":"ref21","first-page":"691","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher G","year":"2024","journal-title":"Gut"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/jcm10081717","article-title":"Non-Alcoholic Fatty Liver Disease Is Associated with Kidney Glomerular Hyperfiltration in Adults with Metabolic Syndrome","volume":"10","author":"Abbate M","year":"2021","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of Non-Alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-Analysis","volume":"11","author":"Musso G","year":"2014","journal-title":"PLoS Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1159\/000343885","article-title":"Association between nonalcoholic liver disease and chronic kidney disease: An ultrasound analysis from NHANES 1988-1994","volume":"36","author":"Sirota JC","year":"2012","journal-title":"Am J Nephrol"},{"key":"ref25","article-title":"New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate with the Risk of Incident Chronic Kidney Disease","volume":"106","author":"Zuo G","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"Marchesini G","year":"2016","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso G","year":"2011","journal-title":"Ann Med"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Inj\u00faria renal e disfun\u00e7\u00e3o metab\u00f3lica associada a doen\u00e7a esteat\u00f3tica do f\u00edgado em pacientes com obesidade"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032025000100503&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:05:46Z","timestamp":1746183946000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032025000100503&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":27,"alternative-id":["S0004-28032025000100503"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.24612025-008","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e25008"}}